Zhejiang Shouxiangu Pharm Co (603896) — Tangible Net Worth Ratio
Zhejiang Shouxiangu Pharm Co (603896) has a Tangible Net Worth Ratio of 84.6% as of March 2026. This metric is calculated by deducting intangible assets (CN¥351.95 Million) from net assets (CN¥2.29 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Zhejiang Shouxiangu Pharm Co net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhejiang Shouxiangu Pharm Co Tangible Net Worth Ratio (2012–2025)
This chart shows how Zhejiang Shouxiangu Pharm Co's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 84.6%, reflecting net assets of CN¥2.29 Billion with intangible assets of CN¥351.95 Million CNY. Also explore net asset momentum of Zhejiang Shouxiangu Pharm Co to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Zhejiang Shouxiangu Pharm Co (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Shouxiangu Pharm Co from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 603896 company net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.3% | CN¥2.26 Billion | CN¥354.28 Million | CN¥3.28 Billion | ▼ -0.3 pp |
| 2024 | 84.6% | CN¥2.29 Billion | CN¥352.86 Million | CN¥3.13 Billion | ▼ -1.1 pp |
| 2023 | 85.7% | CN¥2.17 Billion | CN¥310.98 Million | CN¥3.17 Billion | ▼ -10.2 pp |
| 2022 | 95.9% | CN¥1.91 Billion | CN¥78.16 Million | CN¥2.86 Billion | ▲ +1.0 pp |
| 2021 | 94.9% | CN¥1.62 Billion | CN¥82.98 Million | CN¥1.96 Billion | ▲ +0.8 pp |
| 2020 | 94.1% | CN¥1.33 Billion | CN¥78.58 Million | CN¥1.70 Billion | ▲ +1.0 pp |
| 2019 | 93.1% | CN¥1.17 Billion | CN¥80.84 Million | CN¥1.34 Billion | ▲ +0.6 pp |
| 2018 | 92.5% | CN¥984.74 Million | CN¥74.26 Million | CN¥1.19 Billion | ▲ +1.4 pp |
| 2017 | 91.1% | CN¥869.75 Million | CN¥77.50 Million | CN¥926.34 Million | ▲ +8.6 pp |
| 2016 | 82.4% | CN¥436.93 Million | CN¥76.71 Million | CN¥612.10 Million | ▼ -0.8 pp |
| 2015 | 83.3% | CN¥368.53 Million | CN¥61.71 Million | CN¥605.91 Million | ▼ -15.6 pp |
| 2014 | 98.9% | CN¥320.56 Million | CN¥3.58 Million | CN¥500.99 Million | ▲ +0.1 pp |
| 2013 | 98.8% | CN¥299.50 Million | CN¥3.59 Million | CN¥409.35 Million | ▲ +1.4 pp |
| 2012 | 97.4% | CN¥138.37 Million | CN¥3.54 Million | CN¥274.01 Million | — |